Presentations
[PEGS 2024] Fast-tracking Checkpoint Antibody Development with MOA-Reflective Assays for Cancer & Autoimmune Therapeutics
Checkpoint blockade antibodies are established cancer therapeutics. However, in recent years, agonistic antibodies have emerged as therapeutics not only for…
Read More